Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1084 publications
Cost-effectiveness of sugemalimab plus chemotherapy as first-line therapy in advanced gastric cancer and gastroesophageal junction cancer.
Journal: Annals of medicine
Published: December 10, 2025
A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases.
Journal: Future oncology (London, England)
Published: November 28, 2025
Trastuzumab deruxtecan in HER2-positive stomach or gastroesophageal junction cancer: a plain language summary of the DESTINY-Gastric02 study.
Journal: Future oncology (London, England)
Published: November 26, 2025
Trastuzumab deruxtecan in the treatment of HER2-positive gastric cancer: a comprehensive review.
Journal: Future oncology (London, England)
Published: November 19, 2025
Application of esophageal-tubular gastric asymmetric anastomosis in esophageal and esophagogastric junction cancer
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: October 26, 2025
Disitamab vedotin plus programmed death-1 inhibitor for pre-treated HER2 overexpressed advanced gastric cancer: a multicentre retrospective real-world study.
Journal: Annals of medicine
Published: October 11, 2025
Claudin 18.2 and Other Therapeutic Biomarkers in Gastric and Gastroesophageal Junction Adenocarcinomas.
Journal: The American journal of surgical pathology
Published: August 27, 2025
Addition of immunotherapy to perioperative chemotherapy for resectable gastric and gastroesophageal junction cancer: a meta-analysis of phase 2/3 trials.
Journal: Frontiers in immunology
Published: August 25, 2025
Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 19, 2025
Ultrasound-detected gastric changes related to zolbetuximab-induced emesis: a case series.
Journal: Frontiers in oncology
Published: August 15, 2025
Last Updated: 01/07/2026